Drug intelligence / Profile preview

(1S)-1-(1H-indol-3-ylmethyl)-2-(2-pyridin-4-yl-[1,7]naphtyridin-5-yloxy)-ethylamine

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is an experimental small molecule belonging to the class of bipyridines and oligopyridines. Its structure features an indole moiety linked via a chiral ethylene bridge to a pyridine-substituted naphthyridine core. The compound has been referenced in chemical databases as DB07204 and is primarily used in research settings. There is no available information on its clinical use or primary indication. It has been identified as interacting with cAMP-dependent protein kinase catalytic subunit alpha in humans; however, its pharmacological action remains unknown[1][2][3].

Other names
(2S)-1-(1H-indol-3-yl)-3-{[2-(pyridin-4-yl)-1,7-naphthyridin-5-yl]oxy}propan-2-amine5-\[(2S)-2-amino-3-(1H-indol‑3‑yl)propoxy\]-2-(pyridin‑4‑yl)‑1,7-naphthyridine(2S)-1-(1H-Indol‑3‑yl)–3–{[2–(4-pyridinyl)–1,7-naphthyridin–5–yl]oxy}–propanamine
02

Targets

PKA (Cyclic amp-dependent protein kinase)PRKACB (cAMP-dependent protein kinase catalytic subunit beta)

Beyond the preview

Go deeper on (1S)-1-(1H-indol-3-ylmethyl)-2-(2-pyridin-4-yl-[1,7]naphtyridin-5-yloxy)-ethylamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on (1S)-1-(1H-indol-3-ylmethyl)-2-(2-pyridin-4-yl-[1,7]naphtyridin-5-yloxy)-ethylamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call